It has also been shown that Cacna1a transgenic mice required increased cerebral blood flow and suffered stroke even with milder ischemia, developed larger infarcts, and experienced more severe outcomes (Eikermann‐Haerter et al., 2012; Jolobe, 2012). The gene discussed is CACNA1A; the disease is stroke disorder.